An international, multicenter, prospective randomized trial of adjuvant chemotherapy for stage Ia-IIa non-small cell lung cancer identified as high-risk by a 14-gene molecular assay.

  • Etude concernée: IFCT-2002
  • Auteurs / Authors: D. Spigel
  • Journal / Conference: ASCO
  • Année / Year: 2025
  • PMID: Poster
  • Lien vers la publication: https://ascopubs.org/doi/10.1200/JCO.2025.43.17_suppl.LBA8027